Emergent BioSolutions (United States)
- Research works
- 106 ▲ 59% vs 2018-21
- Citations
- 2.4k 22.4 per fractional work
- Top-10% rate
- 7.7% all institutions 10.0%
- Open access
- 62% world 40%
- International
- 25% world 18%
Not ranked overall: Emergent BioSolutions (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Emergent BioSolutions (United States) work in?
In 2022-now, 58% of research at Emergent BioSolutions (United States) is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (56%), Biochemistry, Genetics and Molecular Biology (13%), Immunology and Microbiology (13%). It does 2.1× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 20 fields, with their numbers
- Health Sciences2257.6%
- Medicine2155.8%
- Health Professions00.8%
- Veterinary00.6%
- Nursing00.4%
- Life Sciences1231.8%
- Physical Sciences37.5%
- Chemistry12.2%
- Environmental Science11.7%
- Materials Science11.3%
- Engineering01.1%
- Earth and Planetary Sciences00.9%
- Physics and Astronomy00.2%
- Computer Science00.1%
- Mathematics00.0%
- Social Sciences13.1%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 13.3×. Every wedge is a field page.
All 20 fields, with their numbers
- Immunology and Microbiology13.32×5 works
- Veterinary4.25×0 works
- Medicine2.90×21 works
- Biochemistry, Genetics and Molecular Biology2.52×5 works
- Pharmacology, Toxicology and Pharmaceutics2.46×0 works
- Chemistry1.43×1 works
- Nursing0.88×0 works
- Neuroscience0.68×0 works
- Agricultural and Biological Sciences0.63×1 works
- Earth and Planetary Sciences0.55×0 works
- Materials Science0.38×0 works
- Environmental Science0.33×1 works
- Health Professions0.31×0 works
- Social Sciences0.21×1 works
- Business, Management and Accounting0.09×0 works
- Physics and Astronomy0.08×0 works
- Engineering0.07×0 works
- Mathematics0.03×0 works
- Arts and Humanities0.03×0 works
- Computer Science0.01×0 works
- Immunology and Microbiology 13.3×
- Veterinary 4.2×
- Medicine 2.9×
- Biochemistry, Genetics and Molecular Biology 2.5×
- Pharmacology, Toxicology and Pharmaceutics 2.5×
- Chemistry 1.4×
- Nursing 0.9×
- Neuroscience 0.7×
- Agricultural and Biological Sciences 0.6×
- Earth and Planetary Sciences 0.6×
- Materials Science 0.4×
- Environmental Science 0.3×
- Health Professions 0.3×
- Social Sciences 0.2×
- Business, Management and Accounting 0.1×
- Physics and Astronomy 0.1×
- Engineering 0.1×
- Mathematics 0.0×
- Arts and Humanities 0.0×
- Computer Science 0.0×
Who are the top researchers at Emergent BioSolutions (United States)?
Ranked on the quality score, Jason S. Richardson, Jason Mendy and Lisa Bedell lead among researchers whose main affiliation is Emergent BioSolutions (United States).
- 1
Jason S. Richardson
United States · #675,428 worldwide 1.1k citations · 29 works
- 2
Jason Mendy
United States · #747,509 worldwide 662 citations · 25 works
- 3
Lisa Bedell
United States · #805,005 worldwide 1k citations · 37 works
- 4
Lo Vang
United States · #896,220 worldwide 761 citations · 23 works
- 5
Gary S. Nabors
United States · #1,176,505 worldwide 1.7k citations · 23 works
- 6
Aruna Sampath
United States · #1,436,799 worldwide 2k citations · 45 works
- 7
Paul W. Shabram
United States · #1,668,872 worldwide 1.3k citations · 25 works
- 8
Robert J. Hopkins
United States · #2,238,425 worldwide 1.3k citations · 31 works
- 9
Joshua J. Reece
United States · #3,194,871 worldwide 478 citations · 18 works
- 10
L. J. Charles
United States · #4,519,163 worldwide 87 citations · 17 works
Which keywords describe research at Emergent BioSolutions (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Epidemiology, Pathogenesis, Vaccine, Substance Use Disorders, Chronic Pain Management, Opioid Prescribing, Immune Response and Pandemic.
- Viral Diseases
- Dendritic Cells
- Anthrax
- Viral Hemorrhagic Fevers
- Cancer Immunotherapy
- Probiotics
- H1N1
- Antibodies
- antibody
- Arboviral Diseases
- Genomics
- Outbreak
- Coronavirus
- Viral Transmission
- Innate Immunity
- Public Health
- Pandemic
- Opioid Prescribing
- Substance Use Disorders
- Pathogenesis
- Epidemiology
- Vaccine
- Chronic Pain Management
- Immune Response
- Vaccine Development
- Immunity
- SARS-CoV-2
- Antigen Presentation
- Ebola Virus
- ACE2 Receptor
- Virus
- Zika Virus
- spike protein
- Gut Microbiota
- Influenza
- Genomic Analysis
- Genetic Diversity
- Zoonotic Infections
- Tularemia
- Tumor Antigen
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology8▲ 5.5×19 topics
- Pathogenesis7▲ 34×6 topics
- Vaccine6▲ 37×8 topics
- Substance Use Disorders5▲ 176×2 topics
- Chronic Pain Management5▲ 391×1 topic
- Opioid Prescribing5▲ 391×1 topic
- Immune Response4▲ 19×8 topics
- Pandemic3▲ 8.8×3 topics
- Vaccine Development3▲ 30×4 topics
- Public Health3▲ 5.0×6 topics
- Immunity3▲ 17×2 topics
- Innate Immunity2▲ 20×4 topics
- SARS-CoV-22▲ 20×4 topics
- Viral Transmission2▲ 41×2 topics
- Antigen Presentation2▲ 57×2 topics
- Coronavirus2▲ 27×2 topics
- Ebola Virus2▲ 183×1 topic
- Outbreak2▲ 135×1 topic
- ACE2 Receptor2▲ 22×2 topics
- Genomics2▲ 17×2 topics
- Virus2▲ 53×2 topics
- Arboviral Diseases2▲ 69×1 topic
- Zika Virus2▲ 69×1 topic
- antibody2▲ 44×1 topic
- spike protein2▲ 44×1 topic
- Antibodies2▲ 76×2 topics
- Gut Microbiota1▲ 10×4 topics
- H1N11▲ 122×1 topic
- Influenza1▲ 91×1 topic
- Probiotics1▲ 16×4 topics
- Genomic Analysis1▲ 13×2 topics
- Cancer Immunotherapy1▲ 20×2 topics
- Genetic Diversity1▲ 7.4×2 topics
- Viral Hemorrhagic Fevers1▲ 73×1 topic
- Zoonotic Infections1▲ 55×1 topic
- Anthrax1▲ 166×1 topic
- Tularemia1▲ 166×1 topic
- Dendritic Cells1▲ 30×1 topic
- Tumor Antigen1▲ 44×1 topic
- Viral Diseases1▲ 41×2 topics
Which research topics does Emergent BioSolutions (United States) publish most on?
By volume in 2022-now: Opioid Use Disorder Treatment, Viral Infections and Outbreaks Research, Mosquito-borne diseases and control and SARS-CoV-2 and COVID-19 Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Opioid Use Disorder Treatment Public Health, Environmental and Occupational Health 5 works
- 2 Viral Infections and Outbreaks Research Infectious Diseases 2 works
- 3 Mosquito-borne diseases and control Public Health, Environmental and Occupational Health 2 works
- 4 SARS-CoV-2 and COVID-19 Research Infectious Diseases 2 works
- 5 Influenza Virus Research Studies Epidemiology 1 works
- 6 Viral Infections and Vectors Infectious Diseases 1 works
- 7 Bacillus and Francisella bacterial research Molecular Biology 1 works
- 8 Immunotherapy and Immune Responses Immunology 1 works
- 9 Respiratory viral infections research Epidemiology 1 works
- 10 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Emergent BioSolutions (United States)'s research output changed?
Output in 2022-2025 was 59% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Emergent BioSolutions (United States) as a percentage of every work published that year, 0.000091% in 2024.
Fractional works of Emergent BioSolutions (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Gaithersburg
- National Institute of Standards and Technology
- Molecular Oncology (United States)
- Scientific Consulting Group
- Robotic Research (United States)
- GenVec
- CVPath Institute
- Identity
- Integrated BioTherapeutics (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Emergent BioSolutions (United States). Posts are plain text and can be reported.